These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 22967858)
21. Relationship between freezing of gait (FOG) and other features of Parkinson's: FOG is not correlated with bradykinesia. Bartels AL; Balash Y; Gurevich T; Schaafsma JD; Hausdorff JM; Giladi N J Clin Neurosci; 2003 Sep; 10(5):584-8. PubMed ID: 12948464 [TBL] [Abstract][Full Text] [Related]
22. L-DOPA-induced behavioral sensitization of motor activity in the MPTP-treated common marmoset as a Parkinson's disease model. Ando K; Inoue T; Itoh T Pharmacol Biochem Behav; 2014 Dec; 127():62-9. PubMed ID: 25449794 [TBL] [Abstract][Full Text] [Related]
23. L-DOPA regulates α-synuclein accumulation in experimental parkinsonism. Deffains M; Canron MH; Teil M; Li Q; Dehay B; Bezard E; Fernagut PO Neuropathol Appl Neurobiol; 2021 Jun; 47(4):532-543. PubMed ID: 33275784 [TBL] [Abstract][Full Text] [Related]
24. L-DOPA pharmacokinetics in the MPTP-lesioned macaque model of Parkinson's disease. Huot P; Johnston TH; Koprich JB; Fox SH; Brotchie JM Neuropharmacology; 2012 Oct; 63(5):829-36. PubMed ID: 22722022 [TBL] [Abstract][Full Text] [Related]
25. Freezing of gait and dementia in parkinsonism: A retrospective case-control study. Palermo G; Frosini D; Corsi A; Giuntini M; Mazzucchi S; Del Prete E; Bonuccelli U; Ceravolo R Brain Behav; 2019 Jun; 9(6):e01247. PubMed ID: 31074064 [TBL] [Abstract][Full Text] [Related]
26. Freezing of Gait in People with Parkinson's Disease: Nature, Occurrence, and Risk Factors. Lord SR; Bindels H; Ketheeswaran M; Brodie MA; Lawrence AD; Close JCT; Whone AL; Ben-Shlomo Y; Henderson EJ J Parkinsons Dis; 2020; 10(2):631-640. PubMed ID: 32116261 [TBL] [Abstract][Full Text] [Related]
27. Freezing of gait in older people: associated conditions, clinical aspects, assessment and treatment. Thanvi B; Treadwell SD Postgrad Med J; 2010 Aug; 86(1018):472-7. PubMed ID: 20709769 [TBL] [Abstract][Full Text] [Related]
28. Effects of deep brain stimulation of the subthalamic nucleus on freezing of gait in Parkinson's disease: a prospective controlled study. Vercruysse S; Vandenberghe W; Münks L; Nuttin B; Devos H; Nieuwboer A J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):871-7. PubMed ID: 24396010 [TBL] [Abstract][Full Text] [Related]
29. A 12-year population-based study of freezing of gait in Parkinson's disease. Forsaa EB; Larsen JP; Wentzel-Larsen T; Alves G Parkinsonism Relat Disord; 2015 Mar; 21(3):254-8. PubMed ID: 25603767 [TBL] [Abstract][Full Text] [Related]
30. Effect of the glycine transporter 1 inhibitor ALX-5407 on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset. Frouni I; Belliveau S; Maddaford S; Nuara SG; Gourdon JC; Huot P Eur J Pharmacol; 2021 Nov; 910():174452. PubMed ID: 34480885 [TBL] [Abstract][Full Text] [Related]
31. The MPTP-treated primate as a model of motor complications in PD: primate model of motor complications. Jenner P Neurology; 2003 Sep; 61(6 Suppl 3):S4-11. PubMed ID: 14504374 [TBL] [Abstract][Full Text] [Related]
32. Balancing between the two: Are freezing of gait and postural instability in Parkinson's disease connected? Bekkers EMJ; Dijkstra BW; Heremans E; Verschueren SMP; Bloem BR; Nieuwboer A Neurosci Biobehav Rev; 2018 Nov; 94():113-125. PubMed ID: 30125601 [TBL] [Abstract][Full Text] [Related]
33. Effects of non-invasive brain stimulation on freezing of gait in parkinsonism: A systematic review with meta-analysis. Kim YW; Shin IS; Moon HI; Lee SC; Yoon SY Parkinsonism Relat Disord; 2019 Jul; 64():82-89. PubMed ID: 30902526 [TBL] [Abstract][Full Text] [Related]
34. Association of freezing of gait and clinical features in patients with Parkinson's disease. Aktürk T; Güven H; Güven B; Çomoğlu S Acta Neurol Belg; 2021 Feb; 121(1):153-159. PubMed ID: 31654392 [TBL] [Abstract][Full Text] [Related]
35. Freezing of gait: moving forward on a mysterious clinical phenomenon. Nutt JG; Bloem BR; Giladi N; Hallett M; Horak FB; Nieuwboer A Lancet Neurol; 2011 Aug; 10(8):734-44. PubMed ID: 21777828 [TBL] [Abstract][Full Text] [Related]
36. DPI-289, a novel mixed delta opioid agonist / mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson's disease. Johnston TH; Versi E; Howson PA; Ravenscroft P; Fox SH; Hill MP; Reidenberg BE; Corey R; Brotchie JM Neuropharmacology; 2018 Mar; 131():116-127. PubMed ID: 29197517 [TBL] [Abstract][Full Text] [Related]
37. Brain 5-HT(2A) receptors in MPTP monkeys and levodopa-induced dyskinesias. Riahi G; Morissette M; Parent M; Di Paolo T Eur J Neurosci; 2011 May; 33(10):1823-31. PubMed ID: 21501255 [TBL] [Abstract][Full Text] [Related]
38. Metabolic activity of the subthalamic nucleus in a primate model of L-dopa-unresponsive parkinsonism. Fernagut PO; Barraud Q; Bezard E; Ghorayeb I; Tison F Neurol Res; 2010 Dec; 32(10):1050-3. PubMed ID: 20810027 [TBL] [Abstract][Full Text] [Related]
39. The effect of botulinum toxin injections to the calf muscles on freezing of gait in parkinsonism: a pilot study. Giladi N; Gurevich T; Shabtai H; Paleacu D; Simon ES J Neurol; 2001 Jul; 248(7):572-6. PubMed ID: 11517998 [TBL] [Abstract][Full Text] [Related]